375 related articles for article (PubMed ID: 29409743)
1. Tolerance induction in HLA disparate living donor kidney transplantation by facilitating cell-enriched donor stem cell Infusion: The importance of durable chimerism.
Leventhal JR; Ildstad ST
Hum Immunol; 2018 May; 79(5):272-276. PubMed ID: 29409743
[TBL] [Abstract][Full Text] [Related]
2. Facilitating cells in tolerance induction for kidney transplantation.
Yolcu ES; Leventhal JR; Ildstad ST
Curr Opin Organ Transplant; 2015 Feb; 20(1):57-63. PubMed ID: 25522139
[TBL] [Abstract][Full Text] [Related]
3. Facilitating cells as a venue to establish mixed chimerism and tolerance.
Jacquet EG; Schanie CL; Fugier-Vivier I; Willer SS; Ildstad ST
Pediatr Transplant; 2003 Oct; 7(5):348-57. PubMed ID: 14738294
[TBL] [Abstract][Full Text] [Related]
4. Tolerance induction in HLA disparate living donor kidney transplantation by donor stem cell infusion: durable chimerism predicts outcome.
Leventhal J; Abecassis M; Miller J; Gallon L; Tollerud D; Elliott MJ; Bozulic LD; Houston C; Sustento-Reodica N; Ildstad ST
Transplantation; 2013 Jan; 95(1):169-76. PubMed ID: 23222893
[TBL] [Abstract][Full Text] [Related]
5. HLA identical non-chimeric and HLA disparate chimeric renal transplant tolerance.
Leventhal JR; Mathew JM; Ildstad S; Salomon DR; Kurian SM; Suthanthiran M; Tambur A; Friedewald J; Gallon L; Charette J; Levitsky J; Kanwar Y; Abecassis M; Miller J
Clin Transpl; 2013; ():145-56. PubMed ID: 25095503
[TBL] [Abstract][Full Text] [Related]
6. Chimerism-based tolerance in organ transplantation: preclinical and clinical studies.
Oura T; Cosimi AB; Kawai T
Clin Exp Immunol; 2017 Aug; 189(2):190-196. PubMed ID: 28369830
[TBL] [Abstract][Full Text] [Related]
7. Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation.
Leventhal J; Abecassis M; Miller J; Gallon L; Ravindra K; Tollerud DJ; King B; Elliott MJ; Herzig G; Herzig R; Ildstad ST
Sci Transl Med; 2012 Mar; 4(124):124ra28. PubMed ID: 22399264
[TBL] [Abstract][Full Text] [Related]
8. Immune reconstitution/immunocompetence in recipients of kidney plus hematopoietic stem/facilitating cell transplants.
Leventhal JR; Elliott MJ; Yolcu ES; Bozulic LD; Tollerud DJ; Mathew JM; Konieczna I; Ison MG; Galvin J; Mehta J; Badder MD; Abecassis MM; Miller J; Gallon L; Ildstad ST
Transplantation; 2015 Feb; 99(2):288-98. PubMed ID: 25594553
[TBL] [Abstract][Full Text] [Related]
9. Tolerance induction: hematopoietic chimerism.
Kawai T; Sachs DH
Curr Opin Organ Transplant; 2013 Aug; 18(4):402-7. PubMed ID: 23838644
[TBL] [Abstract][Full Text] [Related]
10. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic hematopoietic stem-cell transplantation, mixed chimerism, and tolerance in living related donor renal allograft recipients.
Trivedi HL; Vanikar AV; Modi PR; Shah VR; Vakil JM; Trivedi VB; Khemchandani SI
Transplant Proc; 2005 Mar; 37(2):737-42. PubMed ID: 15848518
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic cell-based and non-hematopoietic cell-based strategies for immune tolerance induction in living-donor renal transplantation: A systematic review.
Annamalai C; Kute V; Sheridan C; Halawa A
Transplant Rev (Orlando); 2023 Dec; 37(4):100792. PubMed ID: 37709652
[TBL] [Abstract][Full Text] [Related]
14. Chimerism-Based Tolerance to Kidney Allografts in Humans: Novel Insights and Future Perspectives.
Podestà MA; Sykes M
Front Immunol; 2021; 12():791725. PubMed ID: 35069574
[TBL] [Abstract][Full Text] [Related]
15. Macrochimerism and clinical transplant tolerance.
Scandling JD; Busque S; Lowsky R; Shizuru J; Shori A; Engleman E; Jensen K; Strober S
Hum Immunol; 2018 May; 79(5):266-271. PubMed ID: 29330112
[TBL] [Abstract][Full Text] [Related]
16. HLA molecular mismatches and induced donor-specific tolerance in combined living donor kidney and hematopoietic stem cell transplantation.
Senev A; Tambur AR; Kosmoliaptsis V; Copley HC; García-Sánchez C; Usenko C; Ildstad ST; Leventhal JR
Front Immunol; 2024; 15():1377535. PubMed ID: 38601147
[TBL] [Abstract][Full Text] [Related]
17. A Large-Scale Bank of Organ Donor Bone Marrow and Matched Mesenchymal Stem Cells for Promoting Immunomodulation and Transplant Tolerance.
Johnstone BH; Messner F; Brandacher G; Woods EJ
Front Immunol; 2021; 12():622604. PubMed ID: 33732244
[TBL] [Abstract][Full Text] [Related]
18. The importance of MHC class II in allogeneic bone marrow transplantation and chimerism-based solid organ tolerance in a rat model.
Timrott K; Beetz O; Oldhafer F; Klempnauer J; Vondran FWR; Jäger MD
PLoS One; 2020; 15(5):e0233497. PubMed ID: 32442182
[TBL] [Abstract][Full Text] [Related]
19. Clinical strategy for induction of transplantation tolerance through mixed chimerism.
Cosimi AB; Sachs DH; Sykes M; Kawai T
Clin Transpl; 2013; ():127-34. PubMed ID: 25095501
[TBL] [Abstract][Full Text] [Related]
20. Long-term tolerance to kidney allografts after induced rejection of donor hematopoietic chimerism in a preclinical canine model.
Graves SS; Mathes DW; Georges GE; Kuhr CS; Chang J; Butts TM; Storb R
Transplantation; 2012 Sep; 94(6):562-8. PubMed ID: 22929594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
